Research programme: beta-lactamase inhibitors - University of California
Alternative Names: Beta-lactamase inhibitors research programme - University of CaliforniaLatest Information Update: 22 Jan 2003
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 06 Apr 2001 Product available for licensing
- 06 Apr 2001 Preclinical development for Bacterial infections in USA (Unknown route)